Arkea Bio Corp. filed a Form D with the Securities and Exchange Commission on 2025-10-14.
Arkea Bio Corp. filed a Form D notice of an exempt securities offering with the SEC on October 14, 2025. The filing reports $7M sold. Its industry group is Other Technology. It names Frank Wooten (Executive Officer, Director), Chris Rivest (Executive Officer, Director), Zachariah Serber (Executive Officer, Director) (SEC Form D, October 14, 2025).
In its own words: “ArkeaBio develops a safe, cost-effective methane reducing vaccine for cattle, a scalable solution for sustainable food and climate change.” (arkeabio.com, checked November 1, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Arkea Bio Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Arkea Bio Corp.
Free to see. No signup.
More on the people and the money behind Arkea Bio Corp., from the filings we hold.
Other Technology raises by companies based in Massachusetts, filed in October 2025, largest first.
Get an email when Arkea Bio Corp. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Arkea Bio Corp. raises, hires or launches. No email unless you switch it on.
Watch Arkea Bio Corp. →Get the full cited report on Arkea Bio Corp.
What the filing shows about Arkea Bio Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Arkea Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Arkea Bio Corp.'s address as 500 Rutherford Ave, Ste. 302, Charlestown, MA 02129.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Arkea Bio Corp. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Arkea Bio Corp. is a registered filer with the SEC (CIK 2004801) and has filed since 2023-12-20. 3 filings are on record, the latest on 2026-10-09.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Arkea Bio Corp.'s Form D of 2025-10-14 names Frank Wooten, Chris Rivest, Zachariah Serber and 1 more as its officers, directors or promoters.
Its new offerings report $22M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week.
Frank Wooten is named as Executive Officer and Director on the Form D that Arkea Bio Corp. filed with the SEC on 14 October 2025, one of 4 people that filing names.
Chris Rivest is named as Executive Officer and Director on the Form D that Arkea Bio Corp. filed with the SEC on 14 October 2025, one of 4 people that filing names.
Zachariah Serber is named as Executive Officer and Director on the Form D that Arkea Bio Corp. filed with the SEC on 14 October 2025, one of 4 people that filing names.
Wayne McNee is named as Director on the Form D that Arkea Bio Corp. filed with the SEC on 14 October 2025, one of 4 people that filing names.
4 people named on the filing — 3 holding an executive role and 1 as a director only.
Named as of the 2025-10-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Arkea Bio Corp.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Arkea Bio Corp.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Arkea Bio Corp. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Arkea Bio Corp.You get an alert in MentionFox the next time this company shows up.
If you're behind Arkea Bio Corp.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Arkea Bio Corp.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/arkea-bio-corp-form-d-25000001